Mihajlo Ceraj Ceri, Life Sciences Director, and Marijo Volarevi, VP Business Services at Infotehna, investigate how generic drug manufacturers can benefit utilising document management solutions in managing the drug development process.
Pierre-Olivier Tremblay, Associate Director of Pharmacometrics Clinical Pharmacology at Pharmanet l3, describes how pharmacometrics uses the application of mathematics to analyse vast amounts of data about disease progression, drug response, and clinical behaviour.
Dr. Patricia Lobo, Editor of IPI, speaks with Fran L. DeGrazio of West Pharmaceutical Services, Inc. about reducing the risk of needlestick injuries
New technologies include passive systems that allow for safer injection without altering the caregiver’s administration technique in the hospital and clinical setting.
Formulating oral dosage forms for paediatrics is very challenging due to the specificities of this patient population. Formulators face challenges like ensuring active stability, improving palatability and easing swallowing with specific dosage forms. These issues can be solved with appropriate formulation of attractive dosage forms. Cécile Dusautois of Roquette gives some indications in this article.
Active Pharmaceutical Ingredient (API) Outsourcing – a Perspective from an Integrated Drug Development Solutions Provider
The contract research and manufacturing sector is changing to meet the new demands and opportunities that the marketplace presents. Quality, customer care and delivery are baseline expectations, and new demonstration of additional delivered value at the right price is taking centre stage. In this article, Dr Austin McMordie of Almac presents the argument for effective integration as a new way to deliver outsourced services.
Dr Rüdiger Lomb of World Courier explains that “There is no ‘cookie-cutter’ approach to clinical research” and recommends that pharmaceutical practitioners select their service providers with care.
Roger lamb, Healthcare sector Manager at GS1 UK, examines the issue in this in-depth article. The previous success stories of these technologies being implemented show that other healthcare institutions should be following suit to increase efficiency, reduce costs and, most importantly, improve patient safety.
While many believe chemical indicators may fall short of compliance with global regulations and industry best practices, these devices have, over time, migrated to last-mile cold chain applications in the life science market. Jeff Hawkins of Sensitech Inc. explains the considerations for temperature indicator usage.
Oliver Naucke of Uhlmann Pac-Systeme GmbH explains the concept of – “7×4 Box – My week´s medicine”. To ensure consistent compliance, especially in the case of chronically ill and older people, 7×4 Pharma GmbH commenced a pilot project with the compulsory health insurance AOK Berlin in 2009 to supply patients with individually-packed blisters with their weekly medication.
There are approximately 881,000 malaria-related deaths every year. Drs Nadia elMasry and Chemtai Kipkeu show how Novartis Pharma AG is doing in the fight against malaria.